Isoniazid
- Generic Name
- Isoniazid
- Brand Names
- Isonarif, Isotamine, Isotamine B, Rifamate, Rifater
- Drug Type
- Small Molecule
- Chemical Formula
- C6H7N3O
- CAS Number
- 54-85-3
- Unique Ingredient Identifier
- V83O1VOZ8L
Overview
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Background
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Indication
Isoniazid is used for the treatment of all forms of tuberculosis in which organisms are susceptible. It is also used in combination with rifampin and pyrazinamide.
Associated Conditions
- Active Tuberculosis
- Mycobacterium kansasii infection
- Late phase Tuberculosis
Clinical Trials
FDA Approved Products
Isoniazid
Manufacturer:Aphena Pharma Solutions - Tennessee, LLC
Route:ORAL
Strength:300 mg in 1 1
Approved: 2018/08/22
NDC:71610-108
Isoniazid
Manufacturer:Chartwell RX, LLC
Route:ORAL
Strength:300 mg in 1 1
Approved: 2023/10/26
NDC:62135-709
Isoniazid
Manufacturer:Preferred Pharmaceuticals, Inc.
Route:ORAL
Strength:300 mg in 1 1
Approved: 2023/07/17
NDC:68788-9405
Isoniazid
Manufacturer:Blenheim Pharmacal, Inc.
Route:ORAL
Strength:300 mg in 1 1
Approved: 2015/03/16
NDC:10544-087
Isoniazid
Manufacturer:Sandoz Inc
Route:INTRAMUSCULAR
Strength:100 mg in 1 mL
Approved: 2022/10/11
NDC:0781-3056
Singapore Approved Products
PDP-ISONIAZID TABLET 300 mg
Manufacturer:Pharmascience Inc.
Form:TABLET
Strength:300 mg
Online:Yes
Approved: 1991/10/29
Approval:SIN06651P
ISONIAZID TABLET 100 mg
Manufacturer:ATLANTIC LABORATORIES CORPN LTD
Form:TABLET
Strength:100 mg
Online:Yes
Approved: 1988/05/19
Approval:SIN01302P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath